Post-Vaccination Detection of SARS-CoV-2 Antibody Response with Magnetic Nanoparticle-Based Electrochemical Biosensor System
dc.authorid | AKKUS KAYALI, Gozde/0000-0002-5776-4277 | |
dc.authorscopusid | 55935858800 | |
dc.authorscopusid | 57289928300 | |
dc.authorscopusid | 58618157600 | |
dc.authorscopusid | 58617600500 | |
dc.authorscopusid | 58077774300 | |
dc.authorscopusid | 35611300300 | |
dc.authorscopusid | 6701638388 | |
dc.authorwosid | AKKUS KAYALI, Gozde/HQD-1513-2023 | |
dc.contributor.author | Harmancı, Duygu | |
dc.contributor.author | Balaban Hanoğlu, Simge | |
dc.contributor.author | Akkuş Kayalı, Gözde | |
dc.contributor.author | Durgunlu, Evrim | |
dc.contributor.author | Uçar, Nursima | |
dc.contributor.author | Çiçek, Candan | |
dc.contributor.author | Timur, Suna | |
dc.date.accessioned | 2024-08-25T18:52:07Z | |
dc.date.available | 2024-08-25T18:52:07Z | |
dc.date.issued | 2023 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Here, we report magnetic nanoparticle-based biosensor platforms for the rapid detection of SARS-CoV-2 antibody responses in human serum. The use of the proposed system enabled the detection of anti-SARS-CoV-2 spike (S) and nucleocapsid (N) proteins at a concentration of ng/mL in both buffer and real serum samples. In particular, the protocol, which is considered an indicator of innate immunity after vaccination or post-infection, could be useful for the evaluation of antibody response. We included a total of 48 volunteers who either had COVID-19 but were not vaccinated or who had COVID-19 and were vaccinated with CoronoVac or Biontech. Briefly, in this study, which was planned as a cohort, serum samples were examined 3, 6, and 12 months from the time the volunteers' showed symptoms of COVID-19 with respect to antibody response in the proposed system. Anti-S Ab and anti-N Ab were detected with a limit of detection of 0.98 and 0.89 ng/mL, respectively. These data were confirmed with the corresponding commercial an electrochemiluminescence immunoassay (ECLIA) assays. Compared with ECLIA, more stable data were obtained, especially for samples collected over 6 months. After this period, a drop in the antibody responses was observed. Our findings showed that it could be a useful platform for exploring the dynamics of the immune response, and the proposed system has translational use potential for the clinic. In conclusion, the MNP-based biosensor platform proposed in this study, together with its counterparts in previous studies, is a candidate for determining natural immunity and post-vaccination antibody response, as well as reducing the workload of medical personnel and paving the way for screening studies on vaccine efficacy. | en_US |
dc.description.sponsorship | Ege University Medicine Faculty; Unit of Scientific Research Projects [TTU-2021 278]; Republic of Tuerkiye, Ministry of Development [2016K121190] | en_US |
dc.description.sponsorship | This research was funded by Ege University Medicine Faculty, Unit of Scientific Research Projects (Project Grant No: TTU-2021 278), and the Republic of Tuerkiye, Ministry of Development (Project Grant No: 2016K121190) | en_US |
dc.identifier.doi | 10.3390/bios13090851 | |
dc.identifier.issn | 2079-6374 | |
dc.identifier.issue | 9 | en_US |
dc.identifier.pmid | 37754085 | en_US |
dc.identifier.scopus | 2-s2.0-85172236898 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.3390/bios13090851 | |
dc.identifier.uri | https://hdl.handle.net/11454/102835 | |
dc.identifier.volume | 13 | en_US |
dc.identifier.wos | WOS:001073376800001 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mdpi | en_US |
dc.relation.ispartof | Biosensors-Basel | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | 20240825_G | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | COVID-19 vaccine | en_US |
dc.subject | immunoassay | en_US |
dc.subject | biosensor | en_US |
dc.subject | anti-S antibody | en_US |
dc.subject | anti-N antibody | en_US |
dc.title | Post-Vaccination Detection of SARS-CoV-2 Antibody Response with Magnetic Nanoparticle-Based Electrochemical Biosensor System | en_US |
dc.type | Article | en_US |